Home Page

Action required: Please refresh your browser

We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.

More details about this topic are available here »

Summit Therapeutics to Present at the Piper Jaffray Healthcare Conference

By: Nasdaq / GlobeNewswire - 25 Nov 2015

Back to overview list

Summit Therapeutics plc
("Summit" or the "Company")

SUMMIT THERAPEUTICS TO PRESENT AT THE PIPER JAFFRAY 27 ^TH ANNUAL HEALTHCARE CONFERENCE

Oxford, UK, 25 November 2015 - Summit Therapeutics plc (NASDAQ: SMMT, AIM: SUMM), the drug discovery and development company advancing therapies for Duchenne muscular dystrophy and Clostridium difficile infection, announces that Mr Glyn Edwards, Summit's Chief Executive Officer, will present at the 27 ^th Annual Piper Jaffray Healthcare Conference at 10:30am EST (3:30pm GMT) on Wednesday, 2 December 2015 in New York City.

A live audio webcast of the presentation will be available through the Investors section on the Company's website, www.summitplc.com . A replay of the webcast will be available soon after the live presentation.

About Summit Therapeutics
Summit is a biopharmaceutical company focused on the discovery, development and commercialisation of novel medicines for indications for which there are no existing or only inadequate therapies. Summit is conducting clinical programs focused on the genetic disease DMD and the infectious disease Clostridium difficile infection. Further information is available at www.summitplc.com and Summit can be followed on Twitter (@summitplc).

For more information, please contact:

Summit Glyn Edwards / Richard Pye (UK office) Erik Ostrowski / Michelle Avery (US office)	Tel: +44 (0)1235 443 951 +1 617 225 4455
Cairn Financial Advisers LLP (Nominated Adviser) Liam Murray / Tony Rawlinson	Tel: +44 (0)20 77148 7900
N+1 Singer (Broker) Aubrey Powell / Jen Boorer	Tel: +44 (0)20 7496 3000
Peckwater PR (Financial public relations, UK) Tarquin Edwards	Tel: +44 (0)7879 458 364 tarquin.edwards@peckwaterpr.co.uk
MacDougall Biomedical Communications (US media contact) Chris Erdman	Tel: +1 781 235 3060 cerdman@macbiocom.com

This announcement is distributed by NASDAQ OMX Corporate Solutions on behalf of NASDAQ OMX Corporate Solutions clients.

The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.

Source: Summit Therapeutics plc via GlobeNewswire

HUG#1969279

Related companies:

Summit Corporation plc | Summit Medical Products, Inc.

Back to overview list

to the top ↑